Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune...

Area of Science:

• Rheumatology
• Immunology
• Vaccinology

Background:

• Autoimmune rheumatic diseases (ARD) represent a significant patient population with unique considerations for vaccination.
• The emergence of coronavirus disease 2019 (COVID-19) necessitated specific guidance for vaccine use in individuals with ARD.

Purpose of the Study:

• To develop evidence-based guidance for the use of COVID-19 vaccines in patients diagnosed with autoimmune rheumatic diseases (ARD).

Main Methods:

• A multidisciplinary panel, including rheumatologists and vaccine experts, convened under the Canadian Rheumatology Association (CRA).
• The GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach and evidence-to-decision (EtD) framework were utilized.
• Evidence from COVID-19 trials and indirect evidence for non-COVID-19 vaccines in ARD were synthesized.

Main Results:

• A conditional recommendation was issued supporting COVID-19 vaccination for individuals with ARD.
• The panel concluded that the health benefits of COVID-19 vaccination generally outweigh potential harms for the majority of ARD patients.
• Low to very low certainty of evidence due to indirectness and imprecise estimates informed the conditional grading.

Conclusions:

• The guideline supports the use of COVID-19 vaccines in patients with ARD, emphasizing equitable access to vaccination.
• Further guidance is provided on medication management, implementation strategies, vaccine uptake monitoring, and future research priorities.
• The recommendation is dynamic and will be updated as new evidence becomes available.